AwesomeCapital
Monday, December 31, 2018
15 for ’19: Key Clinical Data to Watch for Next Year
›
It can take decades and billions of dollars to develop a drug, and its fate—and often that of its developer—rests in the outcome of clinic...
Rate Cuts More Likely Than Hikes in 2019
›
The market has now totally priced out rate hikes for the December 11, 2019 FOMC meeting. The rate probability curve...
Your no B.S. guide to losing weight in the New Year
›
Want to lose weight in 2019? It’s time to cut the crap. And that’s not just the junk food sabotaging your diet, or the time suckers keep...
Amneal Pharmaceuticals (AMRX) Top Generic Idea for 2019 – RBC
›
RBC Capital analyst Randall Stanicky called Amneal Pharmaceuticals (NYSE: AMRX) their top generic idea heading into 2019 https://www.str...
Biotech Investors: Mark Your Calendar For These January PDUFA Dates
›
After a strong 2017, biotech stocks are on track to end the year in the red despite a record 59 new molecular entity approvals , some not...
‹
›
Home
View web version